TickerFacts.

NeoGenomics Inc (NEO): Long-Term Debt

Annual figures by period end, from SEC filings.

$341.86M
As of 2025-12-31
+20.0%
10-year compound annual growth
$541.11M2015-12-31: $55.02M2016-12-31: $97.90M2017-12-31: $96.65M2018-12-31: $101.75M2023-12-31: $538.20M2024-12-31: $541.11M2025-12-31: $341.86M$341.86M
2015-12-31 Long-Term Debt (USD) 2025-12-31
Period endedLong-Term DebtChange YoYSource filing
2025-12-31$341.86M-36.8%2026-02-17, Balance as of period end
2024-12-31$541.11M+0.5%2026-02-17, Balance as of period end
2023-12-31$538.20Mn/a2025-02-18, Balance as of period end
No annual figure between 2018-12-31 and 2023-12-31.
2018-12-31$101.75M+5.3%2019-02-26, Balance as of period end
2017-12-31$96.65M-1.3%2018-03-13, Balance as of period end
2016-12-31$97.90M+77.9%2017-03-14, Balance as of period end
2015-12-31$55.02Mn/a2016-04-18, Balance as of period end

Long-Term Debt at similar companies

Companies with the same SEC industry code (Services-Testing Laboratories), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedLong-Term DebtChange YoY
NeoGenomics Inc (NEO)2025-12-31$341.86M-36.8%
UL Solutions Inc. (ULS)2025-12-31$491.00M-33.8%

Compare NEO, ULS side by side · Screen every company in Services-Testing Laboratories ↗